Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Meet Our Team

We thrive on diversity.

Our teams encompass a rich mix of backgrounds, experiences and skills. Passionate scientists, chemists, biochemists, biologists, computational chemists, and pharmacologists work together to make Sygnature the partner of choice, the expert provider of drug discovery services who will do everything to make your project succeed.

Filter by:

Dr Simon Hirst

Chief Executive Officer

VIEW BIO

Prof Andy Black

Non-executive Chairman

VIEW BIO

Dr Paul Overton

Chief Commercial Officer

VIEW BIO

Dr Jonathan Williams

Chief Operating Officer

VIEW BIO

Mrs Victoria Tabiner

Chief Financial Officer

VIEW BIO

Dr Paul Clewlow

Non-executive Director

VIEW BIO

Mr Kevin Keck

Investment Director

VIEW BIO

Mr Barry Robinson

Investment Director

VIEW BIO

Who We Are

Sygnature Discovery prides itself on offering a unique, high-quality, distinctive and tailored integrated drug discovery service to our clients. Our mission is to be admired for the science we do,…

DISCOVER

Working with Us

No two projects will ever be the same, but there are commonly recurring challenges that hinder progress towards a strong candidate molecule. Sygnature draws on the past experience of over…

DISCOVER

Company History

Since 2004 Sygnature Discovery has been offering high-quality drug discovery services and providing guidance and support to customers for the discovery and development of novel medicines. We have grown significantly…

DISCOVER

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.